Evidence map›Paper›PMID 41604045›Full record

ArticleAIDS and behavior2026

Facilitators and Barriers to Home-Based Long-Acting Injectable Antiretroviral Therapy: Clinician Perspectives from the INVITE-Home Study.

Alicia T Bolton, Beth Bourdeau, Jesse O'Shea, Greg Rebchook, Jonathan Van Nuys, Erin Moore, Orlando O Harris, Mallory O Johnson, Starley B Shade, Michelle Palomares and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alicia T BoltonDepartment of Medicine, University of California, San Francisco, USA. alicia.bolton@email.ucr.edu.ORCID http://orcid.org/0009-0007-0268-9277
Beth BourdeauDepartment of Medicine, University of California, San Francisco, USA.
Jesse O'SheaDivision of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Greg RebchookDepartment of Medicine, University of California, San Francisco, USA.
Jonathan Van NuysDepartment of Medicine, University of California, San Francisco, USA.
Erin MooreDepartment of Medicine, University of California, San Francisco, USA.
Orlando O HarrisDepartment of Community Health Systems, School of Nursing, University of California, San Francisco, USA.
Mallory O JohnsonDepartment of Medicine, University of California, San Francisco, USA.
Starley B ShadeDepartment of Medicine, University of California, San Francisco, USA.
Michelle PalomaresDepartment of Medicine, University of California, San Francisco, USA.
Kate BuchaczDivision of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Parya SaberiDepartment of Medicine, University of California, San Francisco, USA.

Funding

ACL HHS U01PS005259National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 5U01PS005259NCHHSTP CDC HHS U01 PS005259
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alternative care delivery modelAntiretroviral therapyCabotegravir and rilpivirineHome-based administrationLong-acting injectablesNon-clinic setting

Identifiers

PMID41604045
PMCPMC12958827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.